Articles by Disease (Ankylosing Spondylitis (as))

Amyloidosis and Auto-Inflammatory Syndromes

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4
Page: 57-65
Author(s): Gilles Grateau, Isabelle Jeru, Saad Rouaghe, Cecile Cazeneuve, Nathalie Ravet, Philippe Duquesnoy, Laurence Cuisset, Catherine Dode, Marc Delpech and Serge Amselem

The Role of Infections in the Pathogenesis of Autoimmune Diseases

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4
Page: 99-103
Author(s): Michael Samarkos and George Vaiopoulos

The Importance of Guidelines in the Development and Application of Probiotics

Journal: Current Pharmaceutical Design
Volume: 11
Page: 11-16
Author(s): Gregor Reid

Current Biological Therapies for Inflammatory Bowel Disease

Journal: Current Pharmaceutical Design
Volume: 10
Page: 4127-4147
Author(s): Daniel C. Baumgart and Axel U. Dignass

The Expanding Role of Tumor Necrosis Factor-α Inhibitors in the Management of Rheumatic Diseases

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1
Page: 479-491
Author(s): Yasser El Miedany

Transcription Factors in Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2787-2796
Author(s): Martin Eggert, Andreas Kluter, Uwe K. Zettl and Gunther Neeck

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-κB

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3
Page: 317-324
Author(s): Teresa Krakauer

Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 3
Page: 239-259
Author(s): Francois Feihl, Mauro Oddo, Bernard Waeber and Lucas Liaudet

Impact of HLA Haplotype on the Response to Antipsychotic Treatment of Schizophrenia

Journal: Current Pharmacogenomics
Volume: 2
Page: 149-155
Author(s): L. Lahdelma and S. Koskimies

Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3
Page: 175-183
Author(s): Paolo Gisondi, Emanuela Gubinelli, Barbara Cocuroccia and Giampiero Girolomoni